PDCD1 and non-small cell lung carcinoma: Baseline enrichment of microbes including Agathobacter, Faecalibacterium, Ruminococcaceae, and Lachnospiraceae have been positively correlated with anti-PD-1 inhibitor efficacy in NSCLC patients (21, 22).